EMEA-001039-PIP04-23 - paediatric investigation plan

Clostridium Botulinum neurotoxin type A (150 kD), free from complexing proteins
PIPHuman

Key facts

Invented name
  • Bocouture
  • Xeomin
Active Substance
Clostridium Botulinum neurotoxin type A (150 kD), free from complexing proteins
Therapeutic area
Nervous system disorders
Decision number
P/0136/2024
PIP number
EMEA-001039-PIP04-23
Pharmaceutical form(s)
Powder for solution for injection
Condition(s) / indication(s)
Treatment of essential tremor
Route(s) of administration
  • Intramuscular use
  • Intraglandular use
Contact for public enquiries

Merz Pharmaceuticals GmbH

Tel. +49 6915031
E-mail: contact@merz.de

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date

Decision

Share this page